Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers Identify New Cause of Genomic Instability

08.08.2003


HHMI Investigator Frederick Alt


Researchers sifting through the indispensable machinery that senses and fixes broken DNA have discovered a new culprit that can induce instability in the genome and thereby set the stage for cancer to develop.

Studies in mice have shown that loss of H2AX, a gene that produces a protein called a histone that is part of the chromosomal structure, can tip the delicate balance of proteins that are curators of the human genome. When H2AX ceases to function properly, lymphomas and solid tumors can arise because errors in the genetic code are not always repaired correctly, according to the new research.

The finding may have important implications for understanding the origin of human cancers because a large number of human tumors are known to contain alterations in the region of chromosome 11 where the H2AX gene is located.



The research was reported in an article published in the August 8, 2003, issue of the journal Cell by Howard Hughes Medical Institute investigator Frederick Alt and colleagues at Children’s Hospital in Boston and Harvard Medical School. Other co-authors are from the Tufts University School of Veterinary Medicine and Brigham and Women’s Hospital.

According to Alt, previous studies by other researchers had shown that H2AX was activated when DNA breaks occur. DNA repair proteins fix genetic damage, but they are also called to action during the normal gene rearrangement that occurs in immune cells when they are readying to battle viruses and other threats.

To explore the implications of knocking out the H2AX gene, lead author Craig Bassing created a line of mice lacking both copies of the H2AX gene. “Both Craig in our lab and Andre Nussenzweig at the National Cancer Institute produced knockout strains that showed an increased level of genomic instability,” said Alt. Nussenzweig and his colleagues have published an article in the same issue of Cell on studies of their H2AX-knockout mice, and have found similar increases in genomic instability and cancer.

According to Alt, the mice lacking only H2AX genes had only a modest increase in cancer, “which is often the case for many genes that produce cancer, because they operate within a system of cellular checks and balances,” he said. “But when you eliminate two genes that may work in concert to maintain good genomic order, you see things happen that are much more dramatic.”

Thus, the researchers created a double-knockout mouse that lacked both H2AX and p53 — a gene that produces a molecular sentinel protein that suppresses proliferation of cells with damaged DNA. In previous studies, Alt and his colleagues had shown that loss of p53 in cells that lacked the DNA-repair process known as non-homologous end-joining (NHEJ) resulted in a dramatic increase in cancers.

“When we deleted both copies of H2AX and both copies of p53, we found a dramatically increased rate of tumors appearing beyond what would be seen with H2AX deficiency alone, and far, far beyond p53 deficiency alone,” said Alt. These cancers developed so rapidly that within a few months all the mice had died, he said. The resulting tumors included both lymphomas arising from aberrant immune cells — which would be common in the loss of NHEJ DNA repair function — and solid tumors, which are not normally seen when NHEJ is compromised.

The researchers also saw cancers arising from malfunction of DNA repair in mature immune cells called B cells. “These kinds of tumors are much more relevant to what goes on in a very large percentage of lymphomas in humans, and adults, in particular,” said Alt.

Alt said that the biggest surprise came when the researchers produced mice missing only one of the two copies of the H2AX gene. “Both surprising and potentially very significant for human cancers was that p53-deficient mice with deletion of one of their two copies of the H2AX gene came down with cancer much earlier,” he said. “They showed a very broad spectrum of tumors that was somewhat different than p53-deficient animals missing both H2AX genes.”

Furthermore, the studies showed that otherwise normal cells that were missing just one H2AX gene had only half the levels of H2AX and also showed genomic instability.

The possibility that only half the levels of the H2AX protein — called “haploinsufficiency” — triggers genomic instability and cancers could be highly significant, said Alt. Such a class of mutation would not have been readily detected in most searches for genes that suppress tumors in humans. Indeed, Bassing discovered that tumors in these mice still had a functioning H2AX gene.

“A major question is why haploinsufficiency of the H2AX protein can cause genomic instability and cancer,” said Alt. “One might explain that quite easily because the protein is not an enzyme, it’s a structural protein. So, if there’s half as much present, it could cause problems in monitoring breaks in the DNA and in recruiting components of the repair machinery.”

What may be especially relevant to human cancers, said Alt, is that the H2AX gene is located in a region of chromosome 11 known to be altered in many human tumors. While there are other potential cancer-causing genes in that region, he said, the current evidence from the mouse model indicates that H2AX will very likely prove a major player in cancer-causing genomic instability.

Alt and his colleagues are now collaborating with scientists at the Dana-Farber Cancer Institute to analyze the status of H2AX genes in a wide range of human cancers. “We believe that the loss of H2AX could prove a major source of the rampant instability associated with the progression of a variety of different tumors,” he said.

Contact: Jim Keeley, mailto:keeleyj@hhmi.org

Jim Keeley | Howard Hughes Medical Institute
Further information:
http://www.hhmi.org

More articles from Life Sciences:

nachricht Cnidarians remotely control bacteria
21.09.2017 | Christian-Albrechts-Universität zu Kiel

nachricht Immune cells may heal bleeding brain after strokes
21.09.2017 | NIH/National Institute of Neurological Disorders and Stroke

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Comet or asteroid? Hubble discovers that a unique object is a binary

21.09.2017 | Physics and Astronomy

Cnidarians remotely control bacteria

21.09.2017 | Life Sciences

Monitoring the heart's mitochondria to predict cardiac arrest?

21.09.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>